Combination of the R263K and M184I/V resistance substitutions against dolutegravir and lamivudine decreases HIV replicative capacity.
| Image |  |
|---|---|
| Description | scientific article published on 9 February 2015 |
| Author/s | |
| Publication date | February 9, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |